BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27527093)

  • 21. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
    Ji KSY; Thomas SM; Roman SA; Czito B; Anderson KL; Frakes J; Adam MA; Sosa JA; Robinson TJ
    J Gastrointest Surg; 2019 May; 23(5):885-894. PubMed ID: 30374818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute.
    Jing W; Guo H; Kong L; Zhang Y; Wang H; An C; Zhu H; Yu J
    Medicine (Baltimore); 2016 Dec; 95(50):e5630. PubMed ID: 27977606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.
    Faiz Z; van Putten M; Verhoeven RHA; van Sandick JW; Nieuwenhuijzen GAP; van der Sangen MJC; Lemmens VEPP; Wijnhoven BPL; Plukker JTM
    Ann Surg Oncol; 2019 Apr; 26(4):986-995. PubMed ID: 30719634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in esophageal cancer survival after surgery.
    Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Bhora F; Flores RM
    J Surg Oncol; 2016 May; 113(6):659-64. PubMed ID: 26865174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes.
    Di Corpo M; Schlottmann F; Strassle PD; Nurczyk K; Patti MG
    J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):989-994. PubMed ID: 31246532
    [No Abstract]   [Full Text] [Related]  

  • 27. Socioeconomic factors in timing of esophagectomy and association with outcomes.
    Chen KA; Strassle PD; Meyers MO
    J Surg Oncol; 2021 Dec; 124(7):1014-1021. PubMed ID: 34254329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.
    Vellayappan BA; Soon YY; Ku GY; Leong CN; Lu JJ; Tey JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010511. PubMed ID: 28829911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
    Worni M; Martin J; Gloor B; Pietrobon R; D'Amico TA; Akushevich I; Berry MF
    J Am Coll Surg; 2012 Nov; 215(5):643-51. PubMed ID: 23084493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study.
    Wani S; Das A; Rastogi A; Drahos J; Ricker W; Parsons R; Bansal A; Yen R; Hosford L; Jankowski M; Sharma P; Cook MB
    Cancer; 2015 Jan; 121(2):194-201. PubMed ID: 25236485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
    Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
    Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
    Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
    Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.
    Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A
    Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective review of patients with locally advanced esophageal cancer treated at the University of Pittsburgh.
    Defoe SG; Pennathur A; Flickinger JC; Heron DE; Gibson MK; Luketich JD; Greenberger JS
    Am J Clin Oncol; 2011 Dec; 34(6):587-92. PubMed ID: 22101387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.
    Rowse PG; Jaroszewski DE; Thomas M; Harold K; Harmsen WS; Shen KR
    Ann Thorac Surg; 2017 Oct; 104(4):1147-1152. PubMed ID: 28842111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
    Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
    Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Esophageal cancer: outcome according to therapeutic strategy].
    Rousseau D; Capitain O; Denis F; Girault S; Poirier AL; Paumier A; Cellier P; Hamy A; Mahé MA; Mesgouez-Nebout N
    Cancer Radiother; 2013 Feb; 17(1):10-20. PubMed ID: 23270680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.